TABLE 2.
Demographic characteristics and baseline measures.
| Rochester (n = 19) | Boston (n = 28) | Levlen/NS (n = 26) | Leuprolide/norethindrone (n = 21) | Total (n = 47) | |
|---|---|---|---|---|---|
| Race (%) | |||||
| White | 14 (29.79) | 21 (44.68) | 20 (42.55) | 15 (31.91) | 35 (74.47) |
| African American | 1 (2.13) | 2 (4.26) | 3 (6.38) | 0 | 3 (6.38) |
| Hispanic | 2 (4.26) | 5 (10.64) | 3 (6.38) | 4 (8.51) | 7 (14.89) |
| Other | 2 (4.26) | 0 | 0 | 2 (4.26) | 2 (4.26) |
| Parity (%) | |||||
| Nulliparous | 12 (25.53) | 22 (46.81) | 19 (40.43) | 15 (31.91) | 34 (72.34) |
| Parous | 7 (14.89) | 6 (12.77) | 7 (14.89) | 6 (12.77) | 13 (27.66) |
| Marital status (%) | |||||
| Married | 5 (10.64) | 10 (21.28) | 10 (21.28) | 5 (10.64) | 15 (31.91) |
| Single | 10 (21.28) | 13 (27.66) | 12 (25.53) | 11 (23.40) | 23 (48.94) |
| Divorced | 3 (6.38) | 5 (10.64) | 3 (6.38) | 5 (10.64) | 8 (17.02) |
| Age, mean (SE) | 27.51 (5.35) | 30.28 (7.00) | 29.92 (7.37) | 28.22 (5.15) | 29.16 (6.47) |
| Outcome measures | |||||
| B&B | 3.94 (1.24) | 3.88 (1.92) | 3.57 (1.47) | 4.35 (1.84) | 3.90 (1.66) |
| BDI | 11.55 (6.85) | 12.66 (8.25) | 11.96 (7.36) | 12.22 (8.53) | 12.06 (7.49) |
| ISS | 18.05 (10.97) | 21.06 (11.77) | 16.90 (9.70) | 24.84 (12.36) | 19.40 (11.33) |
| NRS | 4.63 (2.17) | 4.25 (1.85) | 4.30 (1.77) | 4.83 (1.87) | 4.46 (2.03) |